Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 6
2010 6
2011 7
2012 3
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

21 results
Results by year
Filters applied: . Clear all
Page 1
microRNA involvement in hepatocellular carcinoma.
Negrini M, Gramantieri L, Sabbioni S, Croce CM. Negrini M, et al. Anticancer Agents Med Chem. 2011 Jul;11(6):500-21. doi: 10.2174/187152011796011037. Anticancer Agents Med Chem. 2011. PMID: 21554203 Review.
Breast cancer metastasis: a microRNA story.
Negrini M, Calin GA. Negrini M, et al. Breast Cancer Res. 2008;10(2):203. doi: 10.1186/bcr1867. Epub 2008 Mar 26. Breast Cancer Res. 2008. PMID: 18373886 Free PMC article.
Hedgehog pathway activation in human transitional cell carcinoma of the bladder.
Pignot G, Vieillefond A, Vacher S, Zerbib M, Debre B, Lidereau R, Amsellem-Ouazana D, Bieche I. Pignot G, et al. Br J Cancer. 2012 Mar 13;106(6):1177-86. doi: 10.1038/bjc.2012.55. Epub 2012 Feb 23. Br J Cancer. 2012. PMID: 22361633 Free PMC article.
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.
Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F, Speleman F, Vandesompele J, Weinberg RA. Ma L, et al. Nat Cell Biol. 2010 Mar;12(3):247-56. doi: 10.1038/ncb2024. Epub 2010 Feb 21. Nat Cell Biol. 2010. PMID: 20173740 Free PMC article.
Regulation of cancer aggressive features in melanoma cells by microRNAs.
Greenberg E, Hershkovitz L, Itzhaki O, Hajdu S, Nemlich Y, Ortenberg R, Gefen N, Edry L, Modai S, Keisari Y, Besser MJ, Schachter J, Shomron N, Markel G. Greenberg E, et al. PLoS One. 2011 Apr 25;6(4):e18936. doi: 10.1371/journal.pone.0018936. PLoS One. 2011. PMID: 21541354 Free PMC article.
Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases.
Kahlert C, Klupp F, Brand K, Lasitschka F, Diederichs S, Kirchberg J, Rahbari N, Dutta S, Bork U, Fritzmann J, Reissfelder C, Koch M, Weitz J. Kahlert C, et al. Cancer Sci. 2011 Oct;102(10):1799-807. doi: 10.1111/j.1349-7006.2011.02023.x. Epub 2011 Aug 4. Cancer Sci. 2011. PMID: 21722265 Free article.
miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215.
White NM, Khella HW, Grigull J, Adzovic S, Youssef YM, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA, Evans AJ, Gabril M, Yousef GM. White NM, et al. Br J Cancer. 2011 Nov 22;105(11):1741-9. doi: 10.1038/bjc.2011.401. Epub 2011 Oct 27. Br J Cancer. 2011. PMID: 22033272 Free PMC article.
Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer.
Kojima S, Chiyomaru T, Kawakami K, Yoshino H, Enokida H, Nohata N, Fuse M, Ichikawa T, Naya Y, Nakagawa M, Seki N. Kojima S, et al. Br J Cancer. 2012 Jan 17;106(2):405-13. doi: 10.1038/bjc.2011.462. Epub 2011 Nov 8. Br J Cancer. 2012. PMID: 22068816 Free PMC article.
21 results
Jump to page
Feedback